Å·ÃÀAV

Introduction

The aim of the 3rd Å·ÃÀAV–BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late-stage medicinal chemistry, preclinical or clinical programmes. These case studies will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

Downloads

• Fragments III - final announcement small.pdf
• GSK directions2.pdf

Sponsorship & supporting organisations

GSK,AstraZeneca, Astex Pharmaceuticals, Pfizer, Selcia, Pharma Diagnostics, CCDC

Venue

GlaxoSmithKline

Conference Room, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

Contact information

Mrs Maggi Churchouse
Maggi Churchouse Events, East Barn, Market Weston Road, Thelnetham, Diss, IP22 1JJ, United Kingdom
+44 (0)1359 221004
Contact us by email

---